Tel Aviv, Israel

Oriah Mioduser

This inventor holds 1 USPTO granted patent. Top assignee: Synvaccine Ltd.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Oriah Mioduser. Retrieved from https://idiyas.com/inventor/oriah-mioduser

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Oriah Mioduser: Innovator in Viral Synthetic Nucleic Acid Sequences

Introduction

Oriah Mioduser is a prominent inventor based in Tel Aviv, Israel. He has made significant contributions to the field of synthetic nucleic acids, particularly in the development of viral synthetic nucleic acid sequences. His work has implications for various applications in biotechnology and medicine.

Latest Patents

Oriah Mioduser holds a patent for "Viral synthetic nucleic acid sequences and use thereof." This patent includes nucleic acid molecules that comprise a coding sequence with at least one codon substituted to a synonymous codon. It also covers a modified form of a virus that incorporates these nucleic acid molecules, along with methods for producing these nucleic acid molecules and viruses. He has 1 patent to his name.

Career Highlights

Mioduser is associated with Synvaccine Ltd., where he applies his expertise in synthetic biology. His innovative approach to viral nucleic acids has positioned him as a key figure in the biotechnology sector.

Collaborations

He has collaborated with notable colleagues, including Tamir Tuller and Eli Goz, who share his passion for advancing research in synthetic nucleic acids.

Conclusion

Oriah Mioduser's work in viral synthetic nucleic acid sequences showcases his innovative spirit and dedication to advancing biotechnology. His contributions are paving the way for future developments in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…